학술논문

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Document Type
Journal
Source
BRITISH JOURNAL OF CANCER; MAR 20 2018, 118 6, p770-p776, 7p.
Subject
Language
English
ISSN
15321827